Immunic is trading 10.82% down at $7.09 on October 13, 2026, with no clear company-specific catalyst identified.

  • The biotech sector was weaker, with XBI down 2.01% during the session, while major market indexes were nearly flat.
  • Immunic reported inducement grants on October 13, but available reporting does not establish the announcement as the cause of the stock move.